sfn2014

Nair DV, Al-Badri MM, Peng H, Schenkman N, Pacheco-Quinto J, Eckman CB, Iacono D, Eckman EA (2014) Chronic oxotremorine treatment ameliorates depressive phenotype in a rodent model of Alzheimer’s disease. Neuroscience 2014 Abstracts 670.03. Society for Neuroscience, Washington, DC.

Summary: Alzheimer’s disease (AD) is a progressive neurodegenerative condition that is characterized by changes to brain structure and function. It is estimated that depression and other neuropsychiatric symptoms occur in up to 90% of AD patients, yet the neurobiological basis of these symptoms and their influence on the clinical course of AD remain unclear. Using a rat model of AD-like basal forebrain cholinergic cell loss, our lab has previously shown that central administration of a muscarinic receptor agonist, oxotremorine, for 4 weeks could induce hippocampal neurogenesis and reverse the spatial working memory deficit triggered by cholinergic denervation. Preliminary experiments conducted with this model in our lab also revealed a depressive phenotype emerging between 11 and 15 weeks after cholinergic denervation. The depressive phenotype was detected using a sucrose consumption test and further confirmed by forced swim test. The goal of the present study was to determine whether effects of chronic oxotremorine treatment could ameliorate the depressive phenotype observed after selective cholinergic cell loss in the basal forebrain. Adult female Sprague Dawley rats were injected intracerebroventricularly (icv) with the immunotoxin 192-IgG-saporin (SAP), to induce AD-like basal forebrain cholinergic cell loss. After a 5 week recovery period, the rats then received 8 weeks of icv infusion of either oxotremorine or vehicle (saline) via osmotic minipump. Behavioral testing to assess the depressive phenotype was carried out using the sucrose consumption test every 2 weeks during oxotremorine treatment. The phenotype was further confirmed by forced swim test. Biochemical analysis of a range of markers including tryptophan hydroxylase, the rate limiting enzyme for synthesis of serotonin, was performed after extraction of the brains following the behavioral tests. Results of these experiments demonstrate that oxotremorine treatment prevents the development of the depressive phenotype in SAP-lesioned rats. A number of oxotremorine-treated rats showed increases in tryptophan hydroxylase, suggesting a possible mechanism for the improved behavioral phenotype Based on these data, we propose that 192-IgG saporin lesioned rats may be an effective model for studying the pathophysiology and therapeutic modulation of age- and neurodegeneration-related neuropsychiatric symptoms such as depression.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Phillips K, Kucinski A, Albin R, Sarter M (2014) Impairments in gait, posture and complex movement control in rats modeling the multi-system, cholinergic-dopaminergic losses in PD. Neuroscience 2014 Abstracts 692.21. Society for Neuroscience, Washington, DC.

Summary: In addition to striatal dopamine loss, degeneration of cholinergic neurons in the basal forebrain (BF) and the brainstem pedunculopontine nucleus (PPN) were documented in patients with Parkinson’s disease (PD). Loss of cholinergic projections to cortical, thalamic and midbrain regions have been associated with impairments in gait and postural control and a propensity for falls. We previously demonstrated that loss of cortical cholinergic inputs and the resulting impairments in attentional control ‘unmask’ gait and postural risk factors and thus yielded falls in rats with striatal dopamine loss (Kucinski et al., 2013). For this research we developed a new behavior task for the assessment of gait, postural control, and fall propensity (Michigan Complex Motor Control Task; MCMCT). Here, to determine the contributions of the PPN cholinergic projection system to complex movement control, we also lesioned the cholinergic pars compacta (posterior) division of the PPN by infusing anti-ChAT saporin-coupled immunotoxin. Rats received these lesions either in combination with BF cholinergic (192-IgG-saporin) or dorsomedial striatal dopamine loss (6-OHDA), or all three lesions together (“triples”). MCMCT performance by triples was characterized by more falls than in rats with just PPN lesions, PPN plus striatal dopamine loss, or rats with loss of both BF and PPN cholinergic neurons. High fall rates in triples persisted throughout the 20-day MCMCT testing sequence, indicating that daily practice did not improve the interactions between loss of attentional control and gait and postural deficits that underlie falls. Interestingly, combined loss of BF and PPN cholinergic neurons increased falls relative to controls and single lesions, suggesting that ascending cholinergic PPN loss sufficiently dysregulates striatal dopamine input for BF cholinergic cell loss to ‘unmask’ the impact of the former on striatal dysfunction. Finally, PPN cholinergic cell loss resulted in ballistic postural (recovery) movements and slip-triggered switches to asymmetrical gait. Such behavior was previously observed in rats after electrolytic lesions of the PPN region, considered a model of “Parkinsonian festination” (Cheng et al., 1981) and it may assist in maintaining balance by stabilizing the center of gravity. Collectively, our findings support the hypothesis that PPN cholinergic projections contribute to the mediation of gait symmetry and postural control, and when lesioned in combination with forebrain cholinergic and dopaminergic system, results in profound impairments in the control of complex movements. This research was supported by the Michael J. Fox Foundation.

Related Products: Anti-ChAT-SAP (Cat. #IT-42)

ATS Poster of the Year Winner. Read the featured article in Targeting Trends.

Schreiber WB, Keller S, Knox D (2014) The role of the basal forebrain cholinergic neurons in cued extinction memory. Neuroscience 2014 Abstracts 748.01. Society for Neuroscience, Washington, DC.

Summary: Fear extinction learning and memory requires inhibition of neural activity in amygdala (AMY) nuclei driven by neural substrates in the ventromedial prefrontal cortex (vmPFC), resulting in the behavioral phenotype of a decreased fear response (e.g. low levels of conditioned freezing). Fear extinction memory retrieval is sensitive to contextual feature manipulations, rendering extinction memory retrieval sensitive to hippocampal (HIPP) input to the AMY. Function of the vmPFC and HIPP requires cholinergic innervation from basal forebrain cholinergic neurons (BFCNs), including neurons in the nucleus basalis (NB), horizontal diagonal band of Broca (hDBB), vertical diagonal band of Broca (vDBB), and medial septum (MS). Given the importance of the vmPFC and HIPP for extinction memory, we hypothesized that intact BFCNs would be critical for extinction memory. We found that complete BFCN lesions using 192 IgG-saporin disrupted acquisition of cued fear extinction memory (Experiment 1). Follow-up studies examining more restrictive cholinergic lesions of the MS/vDBB (Experiment 2) or the NB/hDBB (Experiment 3) suggest these two clusters of BFCNs may differentially modulate acquisition and retention of cued extinction memory. The overall results of this study suggest that BFCNs are a component of the fear extinction circuit and a potential target for the pharmacological treatment of psychological disorders thought to stem from extinction memory deficits (e.g. PTSD).

Related Products: 192-IgG-SAP (Cat. #IT-01)

Köppen JR, Stuebing SS, Sieg M, Blackwell AA, Blankenship P, Grisley ED, Cheatwood JL, Wallace DG (2014) Is selective hippocampal cholinergic deafferentation sufficient to produce temporally graded retrograde amnesia?. Neuroscience 2014 Abstracts 749.20. Society for Neuroscience, Washington, DC.

Summary: Dementia of the Alzheimer’s type (DAT) is a neurodegenerative disorder marked by degeneration of basal forebrain structures and is associated with significant mnemonic deficits. The current study used a rat string-pulling task to evaluate whether selective cholinergic deafferentation of the hippocampus is sufficient to produce temporally graded retrograde amnesia. Female rats were pre-trained to pull strings to obtain reinforcement (cashew). Subsequently, rats were trained to discriminate between two scented strings. One scented string was consistently reinforced (+A), while the other scented string was never reinforced (B). After rats met criterion, they either waited two weeks (recent) or six weeks (remote) prior to receiving a sham surgery or infusion of 192-IgG-Saporin into the medial septum. Two weeks later rats were given four days of reversal training during which they experienced the same scented strings; however, the cashew was at the end of the string that was not previously reinforced. Following reversal training, rats were trained on a novel discrimination (+C/D). The results of the current study are consistent with selective cholinergic deafferentation of the hippocampus being sufficient to produce retrograde amnesia that was not temporally graded. First, all rats met criterion in a similar number of days. Rats receiving infusion of 192-IgG-Saporin into the medial septum had a higher number of correct responses during reversal training, relative to sham rats; however, no group differences were observed between recent and remote groups. Next, there were no group differences in the ability to learn a new discrimination. Finally, no group differences we observed in the latency to approach and pull up the string. The results were not caused by deficits in motivation or motor function, but they do reflect impairments in mnemonic function. The current study provides a novel behavioral assessment technique that models the retrograde amnesia characteristics observed in DAT.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Van Kampen JM, Kay DG, Maelicke A (2014) The galantamine prodrug, Memogain®, reverses deficits in hippocampal neurogenesis associated with the loss of basal forebrain cholinergic neurons. Neuroscience 2014 Abstracts 789.21. Society for Neuroscience, Washington, DC.

Summary: Loss of basal forebrain cholinergic innervation of the hippocampus and severe neuronal loss within the hippocampal CA1 region are early hallmarks of Alzheimer’s disease (AD), and are strongly correlated with cognitive status. This loss of cholinergic innervation is a key factor underlying alterations in hippocampal neurogenesis, which are also characteristic of AD. We have previously reported the effects of various cholinergic compounds on hippocampal neurogenesis indicating that acetylcholine serves as a potent neurogenic regulator. Memogain® (GLN 1062) is an inactive galantamine pro-drug with 15 fold higher brain availability than galantamine. It is designed to provide improved blood brain barrier penetration, greater potency, and fewer side effects than the cholinesterase inhibitors currently used for the treatment of Alzheimer’s dementia. This would serve both to promote patient adherence and permit the use of higher doses. Galantamine is unique among the cholinesterase inhibitors in that it also has allosteric actions at α-7 nicotinic receptors, activation of which has been linked to both disease-modifying and cognitive enhancing effects, as well as effects on hippocampal cell proliferation. Here, we describe the neurogenic actions of Memogain® in a rodent model of cholinergic depletion. Infusion of the immunotoxin, 192IgG saporin (SAP), used to induce selective basal forebrain cholinergic cell loss reminiscent of that found in AD, resulted in a pronounced loss of basal forebrain cholinergic neurons and hippocampal ChAT fiber density. Consistent with earlier reports, SAP-lesioned animals had significantly fewer BrdU+ and PCNA+ cells in both the dentate gyrus and CA1 region of the hippocampus, when compared to sham-operated control animals. These animals also displayed significant impairments in spatial working memory, as assessed by a T-maze and the radial arm maze. By contrast, animals treated with Memogain® displayed a restoration of hippocampal cell proliferation, increased neuronal cell counts, normalized neuronal migration, and improvements in cognitive function. Thus, the beneficial effects of Memogain® may extend beyond acute cognitive enhancement, to include disease modification through support of hippocampal neurogenesis.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Becker A, Goldberg M (2014) The effects of targeted intracerebral saporin injection on recovery from stroke. Neuroscience 2014 Abstracts 800.09. Society for Neuroscience, Washington, DC.

Summary: It is well known that the diffuse neuromodulatory systems of the brain play a role in cortical plasticity that may extend to cortical reorganization after brain injury. The basal forebrain cholinergic system in particular is necessary for both cortical plasticity and behavioral recovery from cortical electrolytic lesions. The role of the cholinergic system in recovery from stroke has never been directly investigated. In this experiment, we asked the question: is the basal forebrain cholinergic system in the mouse necessary for behavioral recovery from stroke? To answer this question, we administered intracerebral injections of the selective immunotoxin mu p75-saporin bilaterally to the cholinergic nucleus basalis in young adult mice. Using choline acetyltransferase immunohisochemistry, cresyl violet staining, and fluoro-jade B staining we discovered a dose at which these injections eliminate local cholinergic neurons while leaving other cell types and cholinergic cells outside the nucleus basalis unharmed. We report the effects of these injections on behavioral recovery from a subsequently induced photothrombotic cortical ischemic stroke.

Related Products: mu p75-SAP (Cat. #IT-16)

Li A-J, Wang Q, Davis H, Ritter S (2014) Contribution of hindbrain catecholamine neurons to orexin-induced feeding. Neuroscience 2014 Abstracts 834.08. Society for Neuroscience, Washington, DC.

Summary: Both lateral hypothalamic orexinergic neurons and hindbrain catecholaminergic neurons contribute to feeding behavior. In addition, both phenotypes are widely distributed in the brain and their terminal sites are in many cases overlapping. In the hindbrain, both orexin receptor subtypes (OX1R and OX2R) have been found in close proximity to dopamine-β-hydroxylase (DBH)-expressing cell bodies, raising the question of whether orexin stimulates feeding by activating catecholamine neurons. We tested this hypothesis in the present study. First, we implanted rats with fourth ventricular (4V) cannulas and tested feeding in response to 4V injection of orexin (0.5 nmol). Orexin stimulated feeding in rats, and this stimulation was abolished in rats given paraventricular hypothalamic injections of the retrogradely-transported immunotoxin, anti-DBH-saporin, which targets and destroys DBH-expressing neurons. We then examined hindbrain c-Fos expression in normal rats in response to 4V injection of the same orexin dose that stimulated food intake. Using multiple immunofluorescent labels and confocal microscopy we found that most of the orexin-induced c-Fos-immunoreactive (-ir) neurons in the dorsomedial and ventrolateral medulla were DBH-ir and, moreover, that orexin-ir varicosities were situated in close proximity to the Fos-expressing DBH-ir soma. Together these results suggest that orexin stimulates feeding, at least in part, by activating hindbrain catecholamine neurons.

Related Products: Anti-DBH-SAP (Cat. #IT-03)

Li J, Nelson D, Gibbs R (2014) Cholinergic regulation of aromatase in brain. Neuroscience 2014 Abstracts 640.10. Society for Neuroscience, Washington, DC.

Summary: Our goal is to understand mechanisms by which estrogens can influence brain function and cognition. Estrogens have been shown to influence neuronal plasticity and cognitive performance. Recent studies suggest that, in some cases, local estrogen synthesis can have a greater impact on neuronal survival and plasticity than systemic estrogen administration. Cholinergic projections also have a significant impact on neuronal plasticity in the brain, and recent studies demonstrate critical links between effects of estrogens and effects mediated by cholinergic inputs. In this project we are investigating whether aromatase expression and activity in specific regions of the adult brain are regulated by cholinergic activity. In one experiment, ovariectomized (OVX) rats were treated with the cholinesterase inhibitors donepezil (3 mg/Kg) or galantamine (5 mg/Kg) daily for one week prior to tissue collection. In a second experiment, OVX rats received intraseptal infusions of 192IgG-saporin (SAP) to selectively destroy cholinergic inputs to the hippocampus. Tissues were collected two weeks following the infusions. Different groups of rats were used to evaluate effects on aromatase mRNA and aromatase activity. Effects on aromatase mRNA were evaluated using qRT-PCR. Effects on aromatase activity were evaluated using a novel microsomal assay in which brain tissue microsomes were extracted and activity was measured in vitro by measuring conversion of testosterone to estradiol. Results show an increase in aromatase mRNA in the preoptic area following treatment with galantamine, but no effect in the hippocampus, frontal cortex, or amygdala. Galantamine also produced an increase in aromatase activity in the amygdala, but no significant effect in other brain regions. Donepezil had no significant effects on either aromatase mRNA or activity. Effects of the cholinergic lesions are still being evaluated; however, preliminary results suggest no significant effect on relative levels of aromatase mRNA in the hippocampus. These results indicate that cholinergic manipulations can affect aromatase expression and activity in specific regions of the brain such as the preoptic area and amygdala, with little or no effect in the hippocampus and frontal cortex. This could have important implications for the effects of cholinergic and anticholinergic medications on local estrogen production in the brain.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Patrone LA, Biancardi V, Bicego KC, Gargaglioni LH (2014) Medullary catecholaminergic (CA) neurons modulate hypoxic ventilatory response in neonatal rats (P7-8). Neuroscience 2014 Abstracts 643.10. Society for Neuroscience, Washington, DC.

Summary: It is known that catecholaminergic (CA) neurons are involved in autonomic and respiratory regulation during low O2 conditions in adult mammals. We evaluated the participation of medullary CA neurons of male and female neonatal rats (P7-8) in mediating the hypoxic ventilatory response (HVR) by specifically lesioning them with antidopamine beta-hydroxylase-saporin (DBH-SAP, 42ng / 100nL) injected into the 4th ventricle. We also quantified rates of O2 consumption (VO2) of control and lesioned neonates (P7-8) exposed to hypoxia. Minute ventilation (VE) of neonates was recorded by pressure-plethysmography from the body chamber during normoxia and hypoxia (10% O2), and the VO2 measurement by open flow respirometry. The mammalian HVR typically results in increased VE upon exposure to acute hypoxia. HVR was significantly reduced in male and female lesioned neonatal rats by about 23 and 15%, respectively, (male- control group: 137.3±7.9 (% of baseline) vs. lesioned group: 105.3±2.4 (% of baseline), p<0.01; female- control group: 127.0±3.0 (% of baseline) vs. lesioned group: 108.6±1.7 (% of baseline) p<0.02). The VO2 was decreased in the lesioned newborns, but only the lesioned male group was significantly lower (control group: 76.8±12.14 (% of baseline) vs. lesioned group: 45.3±13.3 (% of baseline) p<0.03). These results suggest that catecholaminergic neurons, specifically from medullary nuclei, exert an excitatory modulation of O2 chemosensitivity in neonatal rats.

Related Products: Anti-DBH-SAP (Cat. #IT-03)

Shim H, Park H-J, Lee H, Shim I (2014) The role of the supramammillary area in spatial learning and memory. Neuroscience 2014 Abstracts 652.05. Society for Neuroscience, Washington, DC.

Summary: The supramammillary area (SuM) of the hypothalamus, although small in size, has wide spread connection with numerous brain structures. It is known that the SuM can control the frequency of the hippocampal theta rhythm, which plays a role in the cognitive functions of the hippocampal formation. In order to examine the role of the specific cells of the SuM in learning and memory, selective cholinergic neurotoxic or excitotoxic lesioned rats of the SuM were tested for spatial memory on the Morris water maze (MWM) test. After the behavior tests, the expression of acetylcholine esterase (AChE) in the hippocampus was studied using the immunohistochemistry. In the MWM test, both lesion of the SuM with 192 IgG-saporin and ibotenic acid produced the impairment of spatial learning and memory. In the immunohistochemistry, the SuM-lesioned rat model by selective cholinergic neurotoxin showed decrease in the AChE expression in the hippocampal CA3. These findings suggest that cholinergic cells of the SuM area play a critical role in the process of consolidation of memory.

Related Products: 192-IgG-SAP (Cat. #IT-01)